)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Aptahem
Aptahem (APTA) investor relations material
Aptahem Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary28 May, 2026
Executive summary
Continued strategic focus on advancing the Apta-1 drug candidate, with strong industry interest and preparations for upcoming clinical phases and potential partnerships.
Strategic collaboration with Hongene Biotech to optimize manufacturing costs, quality, and sustainability for Apta-1.
Rights issue completed after the quarter, raising approximately 3.15 MSEK before costs to strengthen financial resilience and support business development.
Financial highlights
Operating income for Q1 2026 was 574 KSEK, down from 642 KSEK in Q1 2025.
Result after financial items improved to -1,392 KSEK from -2,018 KSEK year-over-year.
Earnings per share were -0.07 SEK, compared to -0.16 SEK in the same quarter last year.
Cash and cash equivalents at March 31, 2026, totaled 1,344 KSEK, up from 1,298 KSEK a year earlier.
Outlook and guidance
Focus remains on cost-effective and value-creating development of Apta-1, with ongoing evaluation of strategic opportunities to maximize asset value.
Management acknowledges a challenging financing climate for small biotech firms but notes increasing interest in differentiated, innovative projects.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Aptahem
- Advancing a novel sepsis therapy, U.S. listing, and global engagement via investor webinar.APTA
Status Update18 May 2026 - Strategic progress, improved results, and new capital define a pivotal year for clinical development.APTAQ4 202512 Feb 2026
- Advanced US listing plans, strengthened IP, and raised 6 MSEK amid ongoing net losses.APTAQ3 202528 Nov 2025
- U.S. listing preparations advance with regulatory, financial, and IP initiatives plus stakeholder updates.APTAStatus Update22 Sep 2025
- Improved financials, strategic partnerships, and U.S. listing plans drive next growth phase.APTAQ2 202528 Aug 2025
- Lower revenue, improved net loss, and new capital support Apta-1's clinical progress.APTAQ3 202413 Jun 2025
- Phase 1 for Apta-1 completed; phase 2 prep, rights issue, and reverse split executed.APTAQ2 202413 Jun 2025
- Q1 2025 saw reduced losses, strategic advances, and a planned rights issue for Aptahem.APTAQ1 20256 Jun 2025
- Net loss narrowed and liquidity improved as Aptahem advanced Apta-1 and secured new partnerships.APTAQ4 20246 Jun 2025
Next Aptahem earnings date
Q2 202628 Aug, 2026
Aptahem
Next Aptahem earnings date
Q2 202628 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage